Subcutaneous Drug Delivery Devices Market Worth $46.6 Billion By 2027

Subcutaneous Drug Delivery Devices Market Growth & Trends

The global subcutaneous drug delivery devices market size is expected to reach USD 46.6 billion by 2027, expanding at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic conditions combined with regular medicine administration to relive disease symptoms has enhanced the demand for in-home drug administration devices. As per the Centers for Disease Control and Prevention (CDC), in 2018, about 54.4 million adults, amounting to 22.7% suffered from arthritis, fibromyalgia, gout, or lupus in the U.S. The CDC further stated that by 2040, an estimated 78.0 million adults accounting for 26.0% will be diagnosed with arthritis.

In addition, a rising number of biologic medicine approvals for the treatment of life-threatening conditions in patients requiring large dose volumes or extended delivery periods accelerate the demand for subcutaneous drug delivery devices. According to the study published by Informa U.K., in February 2019, the total number of medicines in the clinical trial pipeline increased from 53.0% in 2018 to 55.0% in 2019 for parenteral administrations, with an overall decrease in oral medicine formulations from 33.0% in 2018 to 31.0% in 2019.

 Request a free sample copy or view report summary: Subcutaneous Drug Delivery Devices Market Report

Subcutaneous Drug Delivery Devices Market Report Highlights

• North America accounted for the largest revenue share in 2019 owing to the rising prevalence of chronic diseases in the geriatric population and high disposable income

• By product, injection pen is expected to register the highest CAGR during the forecast period owing to ease in providing multi-dose medicine and affordability

• By distribution channel, the retail pharmacies segment accounted for the largest market share as they include large pharmacy chains and attractive schemes and discounts for the novel medicine delivery devices

• Market players are adopting several strategies such as strategic collaborations and product innovations to cater to the increasing patient demand in the global market.

Subcutaneous Drug Delivery Devices Market Segmentation

Grand View Research has segmented the global subcutaneous drug delivery devices market based on product, distribution channel, and region:

Subcutaneous Drug Delivery Devices Product Outlook (Revenue, USD Million, 2016 - 2027)

• Prefilled syringes

• Pen injectors

• Autoinjectors

• Wearable injectors

• Needle-free injectors

Subcutaneous Drug Delivery Devices Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)

• Hospital pharmacies

• Retail pharmacies

• Online pharmacies

Subcutaneous Drug Delivery Devices Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America

  • The U.S.

  • Canada

• Europe

  • The U.K

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Argentina

  • Colombia

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players of Subcutaneous Drug Delivery Devices Market

• Gerresheimer AG

• Medtronic Plc

• Ypsomed AG

• Elcam Medical Group

• Novo Nordisk

• Insulet Corporation

• Becton, Dickinson and Company

• West Pharmaceutical Services, Inc.

• PharmaJet

• Unilife Corporation

• Inolife Sciences